Purpose: The Image-guided Therapy QA Center (ITC) as part of the Advanced Technology QA Consortium (ATC) has played a key role in assisting treatment planning system (TPS) developers in verifying that their DICOM implementations (CT, RT Structure Set, RT Dose, RT Plan, and RT Image) match ATC's conformance statement. This presentation will review lessons learned in this important effort.
Conclusions
• ITC has been a pioneer in the design of DICOM RT objects.
• We feel that ITC's efforts have moved DICOM forward in the field of Radiation Therapy digital data exchange.
• ITC is committed to continue to help vendors with their DICOM implementations.
• DICOM is rapidly becoming the most common format for digital exchange of treatment planning data in ATC-supported clinical trials.
Besides the DICOM ATC-compliant TPSs indicated in Figure 2 , four other TPSs vendors have submitted complete ATC-compliant DICOM data sets to the ITC and are classified as "vendor complete". The ITC is awaiting release of these TPSs versions to permit evaluation by clinical users. The table also shows 9 TPSs that have compliant "RTOG Data Exchange Format" digital data export. This IHE-RO meeting was to set constraints on the RT objects that will be used in a demonstration of DICOM interoperability that is to take place at this years ASTRO meeting (Philadelphia, November 5-9, 2006).
The proportion of data submitted to the ITC for ATC-supported protocols using DICOM continues to rise. Currently, half of all submitted data sets are sent as DICOM RT objects, with the other half in RTOG Data Exchange format.
Efforts to facilitate the export of ATC-compliant DICOM RT data from commercial TPS have established the collection and evaluation of volumetric imaging and treatment planning data as an essential tool for QA of advanced technology clinical trials. The ITC is now contributing its experience to the ASTRO IHE-RO initiative (Integrating the Healthcare Environment -Radiation Oncology). This cooperative effort involving both clinicians and equipment vendors is expected to further benefit clinical trials by increasing the interoperability of TPS components and the uniformity of DICOM RT objects they produce. 
